Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Correction: CD62L is not a reliable biomarker for predicting PML risk in natalizumab-treated R-MS patients.

Literature DB >> 27572432

Correction: CD62L is not a reliable biomarker for predicting PML risk in natalizumab-treated R-MS patients.

Abstract

Entities: Chemical Gene Species

Year: 2016 PMID： 27572432 PMCID： PMC5043140 DOI： 10.1212/WNL.0000000000003082

Source DB: PubMed Journal: Neurology ISSN： 0028-3878 Impact factor: 9.910

Keyword Cloud
References

× No keyword cloud information.

1 in total

1. CD62L is not a reliable biomarker for predicting PML risk in natalizumab-treated R-MS patients.

Authors: Linda A Lieberman; Wanyong Zeng; Carol Singh; Wenting Wang; Kevin L Otipoby; Christine Loh; Tatiana Plavina; Leonid Gorelik; Richard M Ransohoff; Ellen Cahir-McFarland
Journal: Neurology Date: 2015-12-30 Impact factor: 9.910

1 in total